Emcure launches knock-off of Eisai#39;s cancer drug Halaven at 40% lower price in India

Emcure launches knock-off of Eisai#39;s cancer drug Halaven at 40% lower price in India Emcure is confident of overcoming any patent challenge by the innovator, as it claims its version is developed through a non-infringing process.

No comments:

Post a Comment